[1] 刘贞杰, 张艳玲, 王灿灿, 等. 冠心病合并心房颤动患者的相关危险因素分析[J]. 中国循证心血管医学杂志, 2023, 15(8): 979-981. [2] BRUNDEL B J J M, AI X, HILLS M T, et al. Atrial fibrillation[J]. Nat Rev Dis Primers, 2022, 8(1): 21. [3] 巴涛, 常向云, 朱余蓉, 等. 2型糖尿病大鼠rno_circRNA_0003340表达与胰岛素抵抗及胰岛β细胞功能的相关性研究[J]. 中国糖尿病杂志, 2022, 30(5): 358-363. [4] TANG Q, GUO X G, SUN Q, et al. The pre-ablation triglyceride-glucose index predicts late recurrence of atrial fibrillation after radiofrequency ablation in non-diabetic adults[J]. BMC Cardiovasc Disord, 2022, 22(1): 219. [5] ZENG X, HAN D, ZHOU H, et al. Triglyceride-glucose index and homeostasis model assessment-insulin resistance in young adulthood and risk of incident congestive heart failure in midlife: the coronary artery risk development in young adults study[J]. Front Cardiovasc Med, 2022, 9: 944258. [6] SARASTE A, BARBATO E, CAPODANNO D, et al. Imaging in ESC clinical guidelines: chronic coronary syndromes[J]. Eur Heart J Cardiovasc Imaging, 2019, 20(11): 1187-1197. [7] HINDRICKS G, POTPARA T, DAGRES N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC[J]. Eur Heart J, 2021, 42(5): 373-498. [8] SIMENTAL-MENDÍA L E, RODRÍGUEZ-MORÁN M, GUERRERO-ROMERO F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects[J]. Metab Syndr Relat Disord, 2008, 6(4): 299-304. [9] SOLIMAN E Z, SAFFORD M M, MUNTNER P, et al. Atrial fibrillation and the risk of myocardial infarction[J]. JAMA Intern Med, 2014, 174(1): 107-114. [10] LIU Q, CUI H, MA Y, et al. Triglyceride-glucose index associated with the risk of cardiovascular disease: the Kailuan study[J]. Endocrine, 2022, 75(2): 392-399. [11] CHAN Y H, CHANG G J, LAI Y J, et al. Atrial fibrillation and its arrhythmogenesis associated with insulin resistance[J]. Cardiovasc Diabetol, 2019, 18(1): 125. [12] LEE Y, CHA S J, PARK J H, et al. Association between insulin resistance and risk of atrial fibrillation in non-diabetics[J]. Eur J Prev Cardiol, 2020, 27(18): 1934-1941. [13] GUERRERO-ROMERO F, SIMENTAL-MENDÍA L E, GONZÁLEZ-ORTIZ M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp[J]. J Clin Endocrinol Metab, 2010, 95(7): 3347-3351. [14] KHAN S H, SOBIA F, NIAZI N K, et al. Metabolic clustering of risk factors: evaluation of triglyceride-glucose index (TyG index) for evaluation of insulin resistance[J]. Diabetol Metab Syndr, 2018, 10: 74. [15] CHEN S, MEI Q, GUO L, et al. Association between triglyceride-glucose index and atrial fibrillation: a retrospective observational study[J]. Front Endocrinol, 2022, 13: 1047927. [16] ER L K, WU S, CHOU H H, et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals[J]. PLoS One, 2016, 11(3): e0149731. [17] RUAENGSRI C, SCHILL M R, KHIABANI A J, et al. The Cox-maze IV procedure in its second decade: still the gold standard?[J]. Eur J Cardiothorac Surg, 2018, 53(suppl_1): i19-i25. [18] PENG Z, ZHAO R, LIU Y, et al. Effect of preablation glycemic control on outcomes of atrial fibrillation patients with diabetes mellitus following valvular surgery combined with the cox-maze IV procedure[J]. Front Cardiovasc Med, 2022, 9: 898642. |